secwatch.observer — SEC 8-K summary
======================================

Issuer:     ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
CIK:        0000879407
Form:       8-K
Filed at:   2023-01-30T23:59:59+00:00
Accession:  0001628280-23-001757
Event type: other_material
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Arrowhead amends bylaws to add proxy access, update stockholder nomination rules
--------------------------------------------------------------------------------

- Board adopted Second Amended and Restated Bylaws effective January 24, 2023.
- Adds proxy access: stockholder or group of up to 20 owning 3% for 3 years may nominate up to 20% of board or two directors.
- Updates procedural mechanics for stockholder nominations and business proposals.
- Requires a proxy card color other than white for stockholders soliciting proxies from others.
- Conforms bylaws to recent Delaware General Corporation Law amendments.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/879407/000162828023001757/0001628280-23-001757-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/879407/000162828023001757/arwr-20230124.htm
  HTML page:      https://secwatch.observer/filing/0001628280-23-001757

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer